Bausch Health Companies Inc. (TSE:BHC – Get Free Report)’s share price traded up 7.4% on Thursday . The stock traded as high as C$10.40 and last traded at C$9.99. 63,413 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 252,202 shares. The stock had previously closed at C$9.30.
Bausch Health Companies Stock Up 2.3 %
The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58. The firm has a market capitalization of C$2.71 billion, a price-to-earnings ratio of -15.23, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. The firm’s 50-day moving average price is C$10.56 and its 200 day moving average price is C$10.35.
About Bausch Health Companies
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Featured Articles
- Five stocks we like better than Bausch Health Companies
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Election Stocks: How Elections Affect the Stock Market
- DuPont’s Electronics Spinoff: The Start of Something Big
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.
